LAB901 Ltd. partners with South Korean PCR diagnostics firm, Seegene Inc.

22-May-2008

Lab901 Ltd. announced that it has signed a distribution deal with the Korean PCR diagnostics firm Seegene Inc. Under the deal, Lab901 has appointed Seegene as its exclusive diagnostics distributor for the ScreenTape® system in the Korean market. The parties will also co-market their ScreenTape® and Seeplex® products in the global multiplex PCR diagnostics market.

Richard Rowling, Lab901's Director of Sales & Marketing said "Lab901 is delighted to have secured this deal with Seegene. Combining Seegene's highly multiplexed PCR diagnostic kits with Lab901's simple and convenient automated analysis instrument will bring a great boost to both companies' global sales"

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.